EverSource Wealth Advisors’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237 Sell
18
-61
-77% -$723 ﹤0.01% 4234
2026
Q1
$743 Buy
+79
New +$707 ﹤0.01% 3956
2025
Q3
Sell
-67
Closed -$874 4346
2025
Q2
$874 Buy
+67
New +$921 ﹤0.01% 3765
2024
Q2
Sell
-75
Closed -$1.32K 3073
2024
Q1
$1.32K Sell
75
-53
-41% -$1.06K ﹤0.01% 2496
2023
Q4
$2.9K Buy
128
+53
+71% +$1.15K ﹤0.01% 2069
2023
Q3
$1.86K Hold
75
﹤0.01% 2025
2023
Q2
$2.11K Hold
75
﹤0.01% 2009
2023
Q1
$1.67K Sell
75
-29
-28% -$760 ﹤0.01% 1988
2022
Q4
$2.76K Buy
104
+29
+39% +$947 ﹤0.01% 1811
2022
Q3
$2K Hold
75
﹤0.01% 1636
2022
Q2
$2K Sell
75
-264
-78% -$4.95K ﹤0.01% 1473
2022
Q1
$8K Hold
339
﹤0.01% 1056
2021
Q4
$10K Buy
+339
New +$8.22K ﹤0.01% 953

Other funds holding CCRN

EverSource Wealth Advisors's CCRN Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Cross Country Healthcare (CCRN) stake by 77% in Q2 2026, selling an estimated $723 and leaving 18 shares worth $237. The position accounts for ﹤0.01% of the portfolio, ranked #4234.

EverSource Wealth Advisors first reported a position in CCRN in Q4 2021 and has held it in 13 quarters since. The position peaked at $10K in Q4 2021. 151 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • EverSource Wealth Advisors held 18 shares of Cross Country Healthcare worth $237 as of Q2 2026.
  • EverSource Wealth Advisors sold 61 Cross Country Healthcare shares in Q2 2026, an estimated $723.
  • Cross Country Healthcare made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4234 holding.
  • EverSource Wealth Advisors first reported a position in Cross Country Healthcare in Q4 2021 and has held it in 13 quarters since.
  • EverSource Wealth Advisors's Cross Country Healthcare position peaked at $10K in Q4 2021.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.